| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |